Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature.

Hruschak V, Cochran G, Wasan AD.

J Opioid Manag. 2018 Sep/Oct;14(5):345-358. doi: 10.5055/jom.2018.0467.

PMID:
30387858
2.

Baby Boomer's Substance Abuse and Researcher Indifference.

Rosen D, Engel RJ, Beaugard C, Davis N, Cochran G.

J Gerontol Soc Work. 2018 Oct 5:1-13. doi: 10.1080/01634372.2018.1530715. [Epub ahead of print]

PMID:
30289373
3.

Femoral Neck Stress Fractures: MRI Risk Factors for Progression.

Steele CE, Cochran G, Renninger C, Deafenbaugh B, Kuhn KM.

J Bone Joint Surg Am. 2018 Sep 5;100(17):1496-1502. doi: 10.2106/JBJS.17.01593.

PMID:
30180058
4.

Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.

Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Chang CH, Kelley D, Donohue JM.

J Manag Care Spec Pharm. 2018 Sep;24(9):875-885. doi: 10.18553/jmcp.2018.24.9.875.

5.

Excessive Opioid Prescribing After Major Urologic Procedures.

Theisen KM, Myrga JM, Hale N, Cochran G, Sewall C, Macleod LC, Jacobs BL, Davies BJ.

Urology. 2018 Aug 24. pii: S0090-4295(18)30890-2. doi: 10.1016/j.urology.2018.06.057. [Epub ahead of print]

PMID:
30149041
6.

A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial.

Cochran G, Field C, Karp J, Seybert AL, Chen Q, Ringwald W, Hruschak V, Chickering S, Kincman J, Jaber A, Tarter R.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):395-403. doi: 10.1016/j.japh.2018.03.005.

PMID:
29691197
7.

Psychosocial predictors in the transition from acute to chronic pain: a systematic review.

Hruschak V, Cochran G.

Psychol Health Med. 2018 Dec;23(10):1151-1167. doi: 10.1080/13548506.2018.1446097. Epub 2018 Feb 28.

PMID:
29490476
8.

Using Bioinformatics to Treat Hospitalized Smokers: Successes and Challenges of a Tobacco Treatment Service.

Ylioja T, Reddy V, Ambrosino R, Davis EM, Douaihy A, Slovenkay K, Kogut V, Frenak B, Palombo K, Schulze A, Cochran G, Tindle HA.

Jt Comm J Qual Patient Saf. 2017 Dec;43(12):621-632. doi: 10.1016/j.jcjq.2017.06.010.

PMID:
29173282
9.

Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study.

Cochran GT, Hruschak V, Abdullah W, Krans E, Douaihy AB, Bobby S, Fusco R, Tarter R.

J Addict Med. 2018 Jan/Feb;12(1):72-79. doi: 10.1097/ADM.0000000000000370.

PMID:
29140822
10.

Acceptability of an Opioid Relapse Prevention Text-message Intervention for Emergency Department Patients.

Suffoletto B, Yanta J, Kurtz R, Cochran G, Douaihy A, Chung T.

J Addict Med. 2017 Nov/Dec;11(6):475-482. doi: 10.1097/ADM.0000000000000351.

11.

Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid.

Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM.

JAMA. 2017 Aug 22;318(8):750-752. doi: 10.1001/jama.2017.7818. No abstract available.

12.

Medicaid prior authorization and opioid medication abuse and overdose.

Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM.

Am J Manag Care. 2017 May 1;23(5):e164-e171.

13.

Opioid medication misuse among unhealthy drinkers.

Cochran G, McCarthy R, Gordon AJ, Tarter RE.

Drug Alcohol Depend. 2017 Oct 1;179:13-17. doi: 10.1016/j.drugalcdep.2017.06.013. Epub 2017 Jul 14.

14.

Postdischarge smoking cessation in subgroups of hospitalized smokers: A latent class analysis.

Ylioja T, Cochran G, Chang Y, Tindle HA, Rigotti NA.

Subst Abus. 2017 Oct-Dec;38(4):493-497. doi: 10.1080/08897077.2017.1355870. Epub 2017 Jul 20.

15.

Injury Characteristics of Low-Energy Lisfranc Injuries Compared With High-Energy Injuries.

Renninger CH, Cochran G, Tompane T, Bellamy J, Kuhn K.

Foot Ankle Int. 2017 Sep;38(9):964-969. doi: 10.1177/1071100717709575. Epub 2017 Jul 10.

PMID:
28693353
16.

Primary Arthrodesis versus Open Reduction and Internal Fixation for Low-Energy Lisfranc Injuries in a Young Athletic Population.

Cochran G, Renninger C, Tompane T, Bellamy J, Kuhn K.

Foot Ankle Int. 2017 Sep;38(9):957-963. doi: 10.1177/1071100717711483. Epub 2017 Jun 10.

PMID:
28602113
17.

Psychosocial and environmental factors in the prognosis of individuals with chronic pain and comorbid mental health.

Hruschak V Msw Rsw, Cochran G.

Soc Work Health Care. 2017 Aug;56(7):573-587. doi: 10.1080/00981389.2017.1326074. Epub 2017 Jun 8.

PMID:
28594600
18.

Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients?

Cochran G, Rosen D, McCarthy RM, Engel RJ.

J Gerontol Soc Work. 2017 Aug-Oct;60(6-7):443-457. doi: 10.1080/01634372.2017.1327469. Epub 2017 May 10.

PMID:
28489491
19.

Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.

Bahorik AL, Greeno CG, Cochran G, Cornelius JR, Eack SM.

Psychiatry Res. 2017 Jul;253:391-397. doi: 10.1016/j.psychres.2017.04.012. Epub 2017 Apr 5.

20.

Morel-Lavallee Lesion in the Upper Extremity.

Cochran GK, Hanna KH.

Hand (N Y). 2017 Jan;12(1):NP10-NP13. doi: 10.1177/1558944716646776. Epub 2016 Aug 24.

21.

Frequent Experience of LGBQ Microaggression on Campus Associated With Smoking Among Sexual Minority College Students.

Ylioja T, Cochran G, Woodford MR, Renn KA.

Nicotine Tob Res. 2018 Feb 7;20(3):340-346. doi: 10.1093/ntr/ntw305.

PMID:
27988489
22.

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM.

Med Care. 2017 Mar;55(3):291-298. doi: 10.1097/MLR.0000000000000676.

23.

Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.

Cochran G, Hruschak V, Bacci JL, Hohmeier KC, Tarter R.

Res Social Adm Pharm. 2017 Nov;13(6):1055-1061. doi: 10.1016/j.sapharm.2016.11.005. Epub 2016 Nov 15.

24.

ECG Case of the Month: Heart Failure in a Man from Chile.

Glancy DL, Cochran GA, Helmcke FR.

J La State Med Soc. 2016 Sep-Oct;168(5):180-181. Epub 2016 Oct 15.

PMID:
27797350
25.

Experiment and simulation of novel liquid crystal plasma mirrors for high contrast, intense laser pulses.

Poole PL, Krygier A, Cochran GE, Foster PS, Scott GG, Wilson LA, Bailey J, Bourgeois N, Hernandez-Gomez C, Neely D, Rajeev PP, Freeman RR, Schumacher DW.

Sci Rep. 2016 Aug 25;6:32041. doi: 10.1038/srep32041.

26.

Prescription opioid abuse: pharmacists' perspective and response.

Cochran G, Hruschak V, DeFosse B, Hohmeier KC.

Integr Pharm Res Pract. 2016 Aug 25;5:65-73. doi: 10.2147/IPRP.S99539. eCollection 2016. Review.

27.

Comparison of medication safety systems in critical access hospitals: Combined analysis of two studies.

Cochran GL, Barrett RS, Horn SD.

Am J Health Syst Pharm. 2016 Aug 1;73(15):1167-73. doi: 10.2146/ajhp150760.

PMID:
27440623
28.

Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.

Cochran GT, Engel RJ, Hruschak VJ, Tarter RE.

J Pharm Pract. 2017 Oct;30(5):498-505. doi: 10.1177/0897190016656673. Epub 2016 Jul 8.

29.

Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow.

Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM.

J Addict Med. 2016 May-Jun;10(3):210-1. doi: 10.1097/ADM.0000000000000210. No abstract available.

PMID:
27223837
30.

Pediatric Use of Emergency Medical Services: The Role of Chronic Illnesses and Behavioral Health Problems.

Knowlton AR, Weir B, Fields J, Cochran G, McWilliams J, Wissow L, Lawner BJ.

Prehosp Emerg Care. 2016 May-Jun;20(3):362-8. doi: 10.3109/10903127.2015.1115928.

31.

Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Cochran G, Bacci JL, Ylioja T, Hruschak V, Miller S, Seybert AL, Tarter R.

J Am Pharm Assoc (2003). 2016 May-Jun;56(3):248-256.e6. doi: 10.1016/j.japh.2016.02.012. Epub 2016 Mar 24.

32.

Nursing Strategies to Increase Medication Safety in Inpatient Settings.

Bravo K, Cochran G, Barrett R.

J Nurs Care Qual. 2016 Oct-Dec;31(4):335-41. doi: 10.1097/NCQ.0000000000000181.

PMID:
26945258
33.

Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.

Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM.

Addiction. 2016 May;111(5):892-902. doi: 10.1111/add.13270. Epub 2016 Jan 30.

PMID:
26662858
34.

Consumer Opinions of Health Information Exchange, e-Prescribing, and Personal Health Records.

Cochran GL, Lander L, Morien M, Lomelin DE, Brittin J, Reker C, Klepser DG.

Perspect Health Inf Manag. 2015 Nov 1;12:1e. eCollection 2015.

35.

Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.

Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM.

J Addict Med. 2015 Nov-Dec;9(6):470-7. doi: 10.1097/ADM.0000000000000164.

PMID:
26517324
36.

Potential Effect of Coding Differences on Comparisons of Rural and Urban Outcomes.

Cochran GL, Horn SD.

J Am Geriatr Soc. 2015 Oct;63(10):2210-2. doi: 10.1111/jgs.13692. No abstract available.

PMID:
26480995
37.

Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse.

Cochran G, Rubinstein J, Bacci JL, Ylioja T, Tarter R.

J Addict Med. 2015 Sep-Oct;9(5):411-6. doi: 10.1097/ADM.0000000000000148.

38.

Health care provider perceptions of a query-based health information exchange: barriers and benefits.

Cochran GL, Lander L, Morien M, Lomelin DE, Sayles H, Klepser DG.

J Innov Health Inform. 2015 Jun 3;22(2):302-8. doi: 10.14236/jhi.v22i2.135.

39.

Effects of brief intervention on subgroups of injured patients who drink at risk levels.

Cochran G, Field C, Foreman M, Ylioja T, Brown CV.

Inj Prev. 2016 Jun;22(3):221-5. doi: 10.1136/injuryprev-2015-041596. Epub 2015 Jun 29.

40.

Developing a framework of care for opioid medication misuse in community pharmacy.

Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R.

Res Social Adm Pharm. 2016 Mar-Apr;12(2):293-301. doi: 10.1016/j.sapharm.2015.05.001. Epub 2015 May 8.

41.

Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.

Krans EE, Cochran G, Bogen DL.

Clin Obstet Gynecol. 2015 Jun;58(2):370-9. doi: 10.1097/GRF.0000000000000098.

42.

Web-based treatment for substance use disorders: differential effects by primary substance.

Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV.

Addict Behav. 2015 Jun;45:191-4. doi: 10.1016/j.addbeh.2015.02.002. Epub 2015 Feb 8.

43.

Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF.

Subst Abus. 2015;36(2):192-202. doi: 10.1080/08897077.2014.993491. Epub 2015 Feb 11. Review.

44.

Latent Classes Among Recipients of a Brief Alcohol Intervention: A Replication Analysis.

Cochran G, Field C, DiClemente C, Caetano R.

Behav Med. 2016;42(1):29-38. doi: 10.1080/08964289.2014.951305. Epub 2014 Dec 13.

45.

Paternal age and genetic load.

Cochran G, Harpending H.

Hum Biol. 2013 Aug;85(4):515-27.

PMID:
25019186
46.
47.

Clinically relevant characteristics associated with early treatment drug use versus abstinence.

Cochran G, Stitzer M, Nunes EV, Hu MC, Campbell A.

Addict Sci Clin Pract. 2014 Apr 4;9:6. doi: 10.1186/1940-0640-9-6.

48.

Postdischarge nonmedical use of prescription opioids in at-risk drinkers admitted to urban level I trauma centers.

Field CA, Cochran G, Caetano R, Foreman M, Brown CV.

J Trauma Acute Care Surg. 2014 Mar;76(3):833-9. doi: 10.1097/TA.0000000000000100.

PMID:
24553557
49.

Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.

Cochran G, Field C, Lawson K.

J Pharm Pract. 2015 Aug;28(4):404-12. doi: 10.1177/0897190014522064. Epub 2014 Feb 13.

PMID:
24532819
50.

Comparison of medication safety effectiveness among nine critical access hospitals.

Cochran GL, Haynatzki G.

Am J Health Syst Pharm. 2013 Dec 15;70(24):2218-24. doi: 10.2146/ajhp130067.

PMID:
24296844

Supplemental Content

Loading ...
Support Center